Your browser doesn't support javascript.
loading
Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation.
Mahajan, Anubha; Spracklen, Cassandra N; Zhang, Weihua; Ng, Maggie C Y; Petty, Lauren E; Kitajima, Hidetoshi; Yu, Grace Z; Rüeger, Sina; Speidel, Leo; Kim, Young Jin; Horikoshi, Momoko; Mercader, Josep M; Taliun, Daniel; Moon, Sanghoon; Kwak, Soo-Heon; Robertson, Neil R; Rayner, Nigel W; Loh, Marie; Kim, Bong-Jo; Chiou, Joshua; Miguel-Escalada, Irene; Della Briotta Parolo, Pietro; Lin, Kuang; Bragg, Fiona; Preuss, Michael H; Takeuchi, Fumihiko; Nano, Jana; Guo, Xiuqing; Lamri, Amel; Nakatochi, Masahiro; Scott, Robert A; Lee, Jung-Jin; Huerta-Chagoya, Alicia; Graff, Mariaelisa; Chai, Jin-Fang; Parra, Esteban J; Yao, Jie; Bielak, Lawrence F; Tabara, Yasuharu; Hai, Yang; Steinthorsdottir, Valgerdur; Cook, James P; Kals, Mart; Grarup, Niels; Schmidt, Ellen M; Pan, Ian; Sofer, Tamar; Wuttke, Matthias; Sarnowski, Chloe; Gieger, Christian.
Afiliación
  • Mahajan A; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. mahajan.anubha@gene.com.
  • Spracklen CN; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK. mahajan.anubha@gene.com.
  • Zhang W; Genentech, South San Francisco, CA, USA. mahajan.anubha@gene.com.
  • Ng MCY; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Petty LE; Department of Epidemiology and Biostatistics, University of Massachusetts Amherst, Amherst, MA, USA.
  • Kitajima H; Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
  • Yu GZ; Department of Cardiology, Ealing Hospital, London North West Healthcare NHS Trust, London, UK.
  • Rüeger S; Vanderbilt Genetics Institute, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Speidel L; Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Kim YJ; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Horikoshi M; Vanderbilt Genetics Institute, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Mercader JM; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Taliun D; The Advanced Research Center for Innovations in Next-Generation Medicine (INGEM), Tohoku University, Sendai, Japan.
  • Moon S; Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Kwak SH; Cancer Center, Tohoku University Hospital, Tohoku University, Sendai, Japan.
  • Robertson NR; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Rayner NW; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Loh M; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Kim BJ; Genetics Institute, University College London, London, UK.
  • Chiou J; Francis Crick Institute, London, UK.
  • Miguel-Escalada I; Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, Republic of Korea.
  • Della Briotta Parolo P; Laboratory for Genomics of Diabetes and Metabolism, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Lin K; Programs in Metabolism and Medical & Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Bragg F; Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Preuss MH; Harvard Medical School, Boston, MA, USA.
  • Takeuchi F; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.
  • Nano J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Guo X; Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, Republic of Korea.
  • Lamri A; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Nakatochi M; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Scott RA; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Lee JJ; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Huerta-Chagoya A; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Graff M; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Chai JF; Department of Human Genetics, Wellcome Sanger Institute, Hinxton, UK.
  • Parra EJ; Institute of Translational Genomics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
  • Yao J; Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
  • Bielak LF; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Tabara Y; Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology and Research (A*STAR) and National University of Singapore (NUS), Singapore, Singapore.
  • Hai Y; Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, Republic of Korea.
  • Steinthorsdottir V; Biomedical Sciences Graduate Studies Program, University of California San Diego, La Jolla, CA, USA.
  • Cook JP; Internal Medicine Research Unit, Pfizer Worldwide Research, Cambridge, MA, USA.
  • Kals M; Regulatory Genomics and Diabetes, Centre for Genomic Regulation, the Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Grarup N; Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas asociadas (CIBERDEM), Madrid, Spain.
  • Schmidt EM; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Pan I; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Sofer T; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Wuttke M; Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.
  • Sarnowski C; The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gieger C; Department of Gene Diagnostics and Therapeutics, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Nat Genet ; 54(5): 560-572, 2022 05.
Article en En | MEDLINE | ID: mdl-35551307
We assembled an ancestrally diverse collection of genome-wide association studies (GWAS) of type 2 diabetes (T2D) in 180,834 affected individuals and 1,159,055 controls (48.9% non-European descent) through the Diabetes Meta-Analysis of Trans-Ethnic association studies (DIAMANTE) Consortium. Multi-ancestry GWAS meta-analysis identified 237 loci attaining stringent genome-wide significance (P < 5 × 10-9), which were delineated to 338 distinct association signals. Fine-mapping of these signals was enhanced by the increased sample size and expanded population diversity of the multi-ancestry meta-analysis, which localized 54.4% of T2D associations to a single variant with >50% posterior probability. This improved fine-mapping enabled systematic assessment of candidate causal genes and molecular mechanisms through which T2D associations are mediated, laying the foundations for functional investigations. Multi-ancestry genetic risk scores enhanced transferability of T2D prediction across diverse populations. Our study provides a step toward more effective clinical translation of T2D GWAS to improve global health for all, irrespective of genetic background.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Estudio de Asociación del Genoma Completo Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Estudio de Asociación del Genoma Completo Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2022 Tipo del documento: Article